Literature DB >> 18591573

The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study.

Geir Selbaek1, Øyvind Kirkevold, Knut Engedal.   

Abstract

OBJECTIVE: This study investigates the natural course of neuropsychiatric symptoms and the concomitant use of psychotropic medication among a large and representative sample of nursing-home patients with dementia.
METHOD: The authors performed two data collections with structured interviews in a 1-year follow-up cohort-study including 26 nursing homes in four counties in two Norwegian health regions. The main outcome measures were baseline and follow-up frequencies, persistence and incidence of neuropsychiatric symptoms, and the change in neuropsychiatric symptoms with regard to the use of psychotropic medication.
RESULTS: At baseline a representative sample of 1,163 nursing-home patients participated, of whom 933 had dementia. At the follow-up interview after 1 year, 633 of the patients who had dementia at baseline were assessed. Clinically significant neuropsychiatric symptoms were exhibited by 84% of patients with dementia at the baseline or follow-up interviews. Overall persistence of symptoms was 79%. Individual symptoms, such as depression (58%), delusions (56%), and agitation/aggression (47%) had resolved at a high rate. Persistent use of antidepressants (79%), antipsychotics (75%), or any psychotropic drug (88%) was common. There were no differences between users and nonusers of antipsychotics or antidepressants regarding the course of psychosis, agitation, or depression over the 1-year observation period.
CONCLUSION: Neuropsychiatric symptoms are ubiquitous in nursing home patients with dementia. Overall the symptoms are chronically present, whereas individual symptoms often show an intermittent course. Long-term use of psychotropic medication is extensive. Uncertainty about treatment effects emphasizes the need for further treatment trials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18591573     DOI: 10.1097/JGP.0b013e318167ae76

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  43 in total

1.  Subject to empowerment: the constitution of power in an educational program for health professionals.

Authors:  Truls I Juritzen; Eivind Engebretsen; Kristin Heggen
Journal:  Med Health Care Philos       Date:  2013-08

2.  Incidence and predictive factors of depressive symptoms in Alzheimer's disease: the REAL.FR study.

Authors:  C Arbus; V Gardette; C E Cantet; S Andrieu; F Nourhashémi; L Schmitt; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-08       Impact factor: 4.075

3.  Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.

Authors:  M Cary Reid; David A Bennett; Wen G Chen; Basil A Eldadah; John T Farrar; Bruce Ferrell; Rollin M Gallagher; Joseph T Hanlon; Keela Herr; Susan D Horn; Charles E Inturrisi; Salma Lemtouni; Yu Woody Lin; Kaleb Michaud; R Sean Morrison; Tuhina Neogi; Linda L Porter; Daniel H Solomon; Michael Von Korff; Karen Weiss; James Witter; Kevin L Zacharoff
Journal:  Pain Med       Date:  2011-08-11       Impact factor: 3.750

Review 4.  Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.

Authors:  Gianluca Trifiró; Janet Sultana; Edoardo Spina
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

5.  Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials?

Authors:  Helen Lavretsky
Journal:  Am J Geriatr Psychiatry       Date:  2008-07       Impact factor: 4.105

6.  Reducing Psychotropic Drug Use in Nursing Homes in Belgium: An Implementation Study for the Roll-Out of a Practice Improvement Initiative.

Authors:  Maarten Wauters; Monique Elseviers; Laurine Peeters; Dirk De Meester; Thierry Christiaens; Mirko Petrovic
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

Review 7.  Effective pain management in patients with dementia: benefits beyond pain?

Authors:  Elisabeth Flo; Christine Gulla; Bettina S Husebo
Journal:  Drugs Aging       Date:  2014-12       Impact factor: 3.923

8.  Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.

Authors:  Lucy Y Wang; Jane B Shofer; Kirsten Rohde; Kim L Hart; David J Hoff; Yun H McFall; Murray A Raskind; Elaine R Peskind
Journal:  Am J Geriatr Psychiatry       Date:  2009-09       Impact factor: 4.105

9.  Association of antipsychotic use with hospital events and mortality among medicare beneficiaries residing in long-term care facilities.

Authors:  Linda Simoni-Wastila; Priscilla T Ryder; Jingjing Qian; Ilene H Zuckerman; Thomas Shaffer; Lirong Zhao
Journal:  Am J Geriatr Psychiatry       Date:  2009-05       Impact factor: 4.105

10.  Behavioral and psychological symptoms and psychotropic drugs among people with cognitive impairment in nursing homes in 2007 and 2013.

Authors:  Maria Gustafsson; Ulf Isaksson; Stig Karlsson; Per-Olof Sandman; Hugo Lövheim
Journal:  Eur J Clin Pharmacol       Date:  2016-04-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.